StockData
Fortress Biotech, Inc. logo

Fortress Biotech, Inc. (FBIO) stock

FBIONasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as FBIOP
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 9/30
$1.82+0.11 (+6.43%)

Close on Nov 17, 2026Market cap $66.94MP/E –Yield –

Fortress Biotech operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Fortress Biotech's operating income for the twelve months ending Jun 30, 2026 was -$29.35M. For fiscal 2025 it was -$70.22M. The highest annual figure on record is -$2.61M in fiscal 2009.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$70.22M–
FY2024Dec 31, 2024-$110.38M–
FY2023Dec 31, 2023-$142.34M–
FY2022Dec 31, 2022-$203.56M–
FY2021Dec 31, 2021-$188.54M–
FY2020Dec 31, 2020-$94.27M–
FY2019Dec 31, 2019-$110.82M–
FY2018Dec 31, 2018-$120.00M–
FY2017Dec 31, 2017-$89.80M–
FY2016Dec 31, 2016-$65.71M–
FY2015Dec 31, 2015-$50.53M–
FY2014Dec 31, 2014-$20.65M–
FY2013Dec 31, 2013-$35.78M–
FY2012Dec 31, 2012-$27.18M–
FY2011Dec 31, 2011-$35.04M–
FY2010Dec 31, 2010-$9.24M–
FY2009Dec 31, 2009-$2.61M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$10.01M–
Q1 FY2026Mar 31, 2026-$7.74M–
Q4 FY2025Dec 31, 2025-$4.79M–
Q3 FY2025Sep 30, 2025-$6.81M–
Q2 FY2025Jun 30, 2025-$36.47M–
Q1 FY2025Mar 31, 2025-$22.32M–
Q4 FY2024Dec 31, 2024-$23.84M–
Q3 FY2024Sep 30, 2024-$22.10M–
Q2 FY2024Jun 30, 2024-$27.79M–
Q1 FY2024Mar 31, 2024-$36.57M–
Q4 FY2023Dec 31, 2023-$19.61M–
Q3 FY2023Sep 30, 2023-$13.76M–
Q2 FY2023Jun 30, 2023-$50.11M–
Q1 FY2023Mar 31, 2023-$58.87M–
Q4 FY2022Dec 31, 2022-$54.63M–
Q3 FY2022Sep 30, 2022-$50.73M–
Q2 FY2022Jun 30, 2022-$50.93M–
Q1 FY2022Mar 31, 2022-$47.27M–
Q4 FY2021Dec 31, 2021-$62.00M–
Q3 FY2021Sep 30, 2021-$49.92M–
Q2 FY2021Jun 30, 2021-$42.86M–
Q1 FY2021Mar 31, 2021-$30.02M–
Q4 FY2020Dec 31, 2020-$24.30M–
Q3 FY2020Sep 30, 2020-$23.04M–
Q2 FY2020Jun 30, 2020-$25.40M–
Q1 FY2020Mar 31, 2020-$21.53M–
Q4 FY2019Dec 31, 2019-$30.38M–
Q3 FY2019Sep 30, 2019-$22.54M–
Q2 FY2019Jun 30, 2019-$25.29M–
Q1 FY2019Mar 31, 2019-$32.61M–
Q4 FY2018Dec 31, 2018-$41.21M–
Q3 FY2018Sep 30, 2018-$28.21M–
Q2 FY2018Jun 30, 2018-$25.40M–
Q1 FY2018Mar 31, 2018-$34.17M–
Q4 FY2017Dec 31, 2017-$30.62M–
Q3 FY2017Sep 30, 2017-$31.80M–
Q2 FY2017Jun 30, 2017-$25.50M–
Q1 FY2017Mar 31, 2017-$19.13M–
Q4 FY2016Dec 31, 2016-$32.22M–
Q3 FY2016Sep 30, 2016-$17.18M–

More Fortress Biotech figures

See a number that looks wrong?